With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy ...

In fact, the recent months have included some of the more significant achievements in Arrowhead's history. First, on November ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...

In biology, many RNA molecules act as sophisticated microscopic machines. Among them, riboswitches function as tiny biological sensors, changing their 3D shape upon binding to a specific metabolite.